COVID-19 Delaying Rare Disease and Gene Therapy Trials, Pharma Execs Say
News, syndicated
While the ongoing COVID-19 pandemic won’t have much of an impact on cash available for new biotech startups, it has begun to cause delays in the development of gene therapies ... Read more